Healthcare provider profile · identity verified

Bryan Daniel O'Connell, M.D.

Internal Medicine · JENKINTOWN, PA · NPI 1023202157

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	656	204
Amlodipine Besylate	Amlodipine Besylate	512	154
Losartan Potassium	Losartan Potassium	329	97
Levothyroxine Sodium	Levothyroxine Sodium	314	85
Lisinopril	Lisinopril	258	84
Rosuvastatin Calcium	Rosuvastatin Calcium	251	79
Hydrochlorothiazide	Hydrochlorothiazide	225	71
Omeprazole	Omeprazole	220	68
Metoprolol Succinate	Metoprolol Succinate	205	63
Simvastatin	Simvastatin	197	63
Metformin Hcl	Metformin Hcl	173	59
Pantoprazole Sodium	Pantoprazole Sodium	173	56
Gabapentin	Gabapentin	157	45
Metformin Hcl Er	Metformin Hcl	156	47
Famotidine	Famotidine	141	43
Lorazepam	Lorazepam	120	38
Alprazolam	Alprazolam	116	27
Tamsulosin Hcl	Tamsulosin Hcl	113	36
Sertraline Hcl	Sertraline Hcl	110	36
Allopurinol	Allopurinol	100	27
Carvedilol	Carvedilol	96	32
Fluticasone Propionate	Fluticasone Propionate	95	39
Eliquis	Apixaban	92	21
Jardiance	Empagliflozin	87	20
Bupropion Xl	Bupropion Hcl	86	24
Furosemide	Furosemide	83	34
Potassium Chloride	Potassium Chloride	78	16
Duloxetine Hcl	Duloxetine Hcl	77	23
Pravastatin Sodium	Pravastatin Sodium	76	22
Trazodone Hcl	Trazodone Hcl	75	27
Escitalopram Oxalate	Escitalopram Oxalate	73	24
Clonazepam	Clonazepam	72	16
Ipratropium Bromide	Ipratropium Bromide	71	25
Montelukast Sodium	Montelukast Sodium	71	20
Albuterol Sulfate Hfa	Albuterol Sulfate	67	27
Zolpidem Tartrate	Zolpidem Tartrate	63	24
Meloxicam	Meloxicam	53	15
Nifedipine Er	Nifedipine	53	12
Valsartan	Valsartan	53	16
Metoprolol Tartrate	Metoprolol Tartrate	51	14
Mirtazapine	Mirtazapine	50	17
Mounjaro	Tirzepatide	49	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	49	13
Diazepam	Diazepam	45	13
Ezetimibe	Ezetimibe	45	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	44	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	44	12
Buspirone Hcl	Buspirone Hcl	43	suppressed
Finasteride	Finasteride	43	14
Synthroid	Levothyroxine Sodium	41	14
Trulicity	Dulaglutide	41	suppressed
Atenolol	Atenolol	40	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	13
Paroxetine Hcl	Paroxetine Hcl	40	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	39	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	11
Oxycodone Hcl	Oxycodone Hcl	39	suppressed
Azithromycin	Azithromycin	38	31
Cephalexin	Cephalexin	38	30
Hydralazine Hcl	Hydralazine Hcl	38	11
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	suppressed
Tramadol Hcl	Tramadol Hcl	35	15
Chlorthalidone	Chlorthalidone	34	suppressed
Glimepiride	Glimepiride	34	suppressed
Pregabalin	Pregabalin	34	11
Clopidogrel	Clopidogrel Bisulfate	32	suppressed
Warfarin Sodium	Warfarin Sodium	32	suppressed
Methylprednisolone	Methylprednisolone	30	21
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Alendronate Sodium	Alendronate Sodium	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Ibuprofen	Ibuprofen	27	12
Aripiprazole	Aripiprazole	26	suppressed
Ozempic	Semaglutide	26	suppressed
Glipizide Er	Glipizide	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Valacyclovir	Valacyclovir Hcl	24	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	19
Irbesartan	Irbesartan	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	18
Celecoxib	Celecoxib	22	suppressed
Naproxen	Naproxen	22	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Temazepam	Temazepam	21	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Ketoconazole	Ketoconazole	17	11
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Prednisone	Prednisone	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Ramipril	Ramipril	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Flecainide Acetate	Flecainide Acetate	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Phenobarbital	Phenobarbital	13	suppressed
Risperidone	Risperidone	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Folic Acid	Folic Acid	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Torsemide	Torsemide	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error